Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7MG1

Concanavalin A crystallized without DNA glycoconjugate

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Source detailsAPS BEAMLINE 21-ID-G
Synchrotron siteAPS
Beamline21-ID-G
Temperature [K]100
Detector technologyCCD
Collection date2020-07-19
DetectorRAYONIX MX-300
Wavelength(s)0.9786
Spacegroup nameI 2 2 2
Unit cell lengths61.190, 85.180, 89.250
Unit cell angles90.00, 90.00, 90.00
Refinement procedure
Resolution61.620 - 2.000
R-factor0.206
Rwork0.203
R-free0.26200
Structure solution methodMOLECULAR REPLACEMENT
Starting model (for MR)1jbc
RMSD bond length0.008
RMSD bond angle1.516
Data reduction softwareiMOSFLM
Data scaling softwareSCALA
Phasing softwarePHASER
Refinement softwareREFMAC (5.8.0258)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]61.6202.110
High resolution limit [Å]2.0002.000
Rmerge0.1120.440
Number of reflections141201906
<I/σ(I)>3.199
Completeness [%]92.282.4
Redundancy7.126.26
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, SITTING DROP7295Sitting drop comprising 1 uL of Concanavalin A (32 uM) + 1 uL crystallization condition (Helix screen, condition H3: 0.1 M potassium chloride, 0.005 M barium chloride dihydrate, 0.05 M bis-Tris (pH 7), 12% w/v PEG 8000). Reservoir contained 70 uL of crystallization condition.

251422

PDB entries from 2026-04-01

PDB statisticsPDBj update infoContact PDBjnumon